Table 1 Baseline characteristics among all adults
Total | Intralipid* | 4-OLE | p value | |
|---|---|---|---|---|
(N = 1200) | (N = 341) | (N = 859) | ||
Age (in years), median (IQR) | 58.5 (44.0–68.0) | 56.0 (42.0–67.0) | 59.0 (46.0–68.0) | 0.049 |
Male | 635 (52.92%) | 188 (55.13%) | 447 (52.04%) | 0.33 |
Race | ||||
Caucasian/white | 764 (63.67%) | 225 (65.98%) | 539 (62.75%) | 0.31 |
Black or African-American | 333 (27.75%) | 93 (27.27%) | 240 (27.94%) | |
Other | 103 (8.58%) | 23 (6.74%) | 80 (9.31%) | |
Hispanic | 44 (3.67%) | 10 (2.93%) | 34 (3.96%) | 0.39 |
Payor | ||||
MCO | 373 (31.08%) | 101 (29.62%) | 272 (31.66%) | 0.87 |
Medicaid | 99 (8.25%) | 30 (8.80%) | 69 (8.03%) | |
Medicare | 568 (47.33%) | 162 (47.51%) | 406 (47.26%) | |
Other | 160 (13.33%) | 48 (14.08%) | 112 (13.04%) | |
Comorbidity at admission | ||||
Malnutrition | 788 (65.67%) | 226 (66.28%) | 562 (65.42%) | 0.78 |
Congestive heart failure | 121 (10.08%) | 46 (13.49%) | 75 (8.73%) | 0.014 |
Cancer | 247 (20.58%) | 89 (26.10%) | 158 (18.39%) | 0.003 |
Chronic pulmonary disease | 140 (11.67%) | 49 (14.37%) | 91 (10.59%) | 0.07 |
Liver disease | 108 (9.00%) | 37 (10.85%) | 71 (8.27%) | 0.16 |
Renal failure | 146 (12.17%) | 57 (16.72%) | 89 (10.36%) | 0.002 |
Diabetes mellitus | 189 (15.75%) | 59 (17.30%) | 130 (15.13%) | 0.35 |
Body weight, kg, median (IQR) | 74.7 (61.0–88.2) | 71.8 (60.5–87.1) | 72.4 (60.6–87.4) | 0.37 |
BMI (kg/m2), median (IQR) | 25.5 (21.6–29.6) | 25.4 (21.4–29.2) | 25.5 (21.7–29.6) | 0.81 |
ED admission | 452 (37.67%) | 116 (34.02%) | 336 (39.12%) | 0.1 |
ICU admission | 447 (37.25%) | 110 (32.26%) | 337 (39.23%) | 0.024 |
Mechanical ventilation | 223 (18.58%) | 59 (17.30%) | 164 (19.09%) | 0.47 |
Antibiotic use | 1088 (90.67%) | 312 (91.50%) | 776 (90.34%) | 0.53 |
Use of insulin | 582 (48.50%) | 173 (50.73%) | 409 (47.61%) | 0.33 |
Use of statin | 220 (18.33%) | 56 (16.42%) | 164 (19.09%) | 0.28 |